FIASP PENFILL

Peak

insulin aspart injection

BLASUBCUTANEOUSSOLUTION
Approved
Sep 2017
Lifecycle
Peak
Competitive Pressure
30/100

Mechanism of Action

metabolism. Insulins, including insulin aspart, the active ingredient in FIASP, exert their specific action through binding to insulin receptors. Receptor-bound insulin lowers blood glucose by facilitating cellular uptake of glucose into skeletal muscle and adipose tissue and by inhibiting the…

Pharmacologic Class:

Insulin Analog